Back to OLMA
MORGAN STANLEY OLMA Position History
Olema Pharmaceuticals, Inc. • Healthcare
Quarters held
26
Latest value
$22.1M
Q2 2026
Peak value
$22.1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $25K |
| Q3 2025 | $198K |
| Q3 2025 | $199K |
| Q3 2025 | $1.4M |
| Q3 2025 | $985K |
| Q3 2025 | $12.4M |
| Q4 2025 | $98K |
| Q4 2025 | $112K |
| Q4 2025 | $649K |
| Q4 2025 | $2K |
| Q4 2025 | $4.4M |
| Q4 2025 | $11.4M |
| Q1 2026 | $84K |
| Q1 2026 | $61K |
| Q1 2026 | $1.4M |
| Q1 2026 | $498K |
| Q1 2026 | $249K |
| Q1 2026 | $1.5M |
| Q1 2026 | $910 |
| Q1 2026 | $14.4M |
| Q2 2026 | $90K |
| Q2 2026 | $51K |
| Q2 2026 | $334K |
| Q2 2026 | $292K |
| Q2 2026 | $52K |
| Q2 2026 | $22.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $22.1M | 1.77M | — | — |
| Q2 2026 | $52K | 4.2K | — | — |
| Q2 2026 | $292K | 23.3K | — | — |
| Q2 2026 | $334K | 26.7K | — | — |
| Q2 2026 | $51K | 4.1K | — | — |
| Q2 2026 | $90K | 7.2K | — | — |
| Q1 2026 | $14.4M | 963.6K | — | — |
| Q1 2026 | $910 | 61 | — | — |
| Q1 2026 | $1.5M | 99.2K | — | — |
| Q1 2026 | $249K | 16.7K | — | — |
| Q1 2026 | $498K | 33.4K | — | — |
| Q1 2026 | $1.4M | 93.0K | — | — |
| Q1 2026 | $61K | 4.1K | — | — |
| Q1 2026 | $84K | 5.7K | — | — |
| Q4 2025 | $11.4M | 456.8K | — | — |
| Q4 2025 | $4.4M | 174.5K | — | — |
| Q4 2025 | $2K | 93 | — | — |
| Q4 2025 | $649K | 25.9K | — | — |
| Q4 2025 | $112K | 4.5K | — | — |
| Q4 2025 | $98K | 3.9K | — | — |
| Q3 2025 | $12.4M | 1.27M | — | — |
| Q3 2025 | $985K | 100.6K | — | — |
| Q3 2025 | $1.4M | 145.5K | — | — |
| Q3 2025 | $199K | 20.3K | — | — |
| Q3 2025 | $198K | 20.2K | — | — |
| Q3 2025 | $25K | 2.6K | — | — |